NCT03109977
- Conditions
- HER2-positive Carcinoma, HER2-positive Primary Malignancy
- Locations
-
- Memorial Slaon-Kettering Cancer Center New York, United States
Clinical trial condition
HER2-positive Carcinoma
Explore clinical trials studying HER2-positive Carcinoma. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies